APT Medical Inc. (SHA:688617)

Market Cap	42.51B
Revenue (ttm)	2.07B
Net Income (ttm)	673.48M
Shares Out	96.94M
EPS (ttm)	6.96
PE Ratio	63.00
Forward PE	46.13
Dividend	1.38 (0.32%)
Ex-Dividend Date	n/a

Volume	319,308
Average Volume	624,950
Open	437.00
Previous Close	438.50
Day's Range	435.63 - 456.34
52-Week Range	293.49 - 480.00
Beta	-0.33
RSI	69.51
Earnings Date	Apr 23, 2025

About APT Medical

APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guid...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,155
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2024, APT Medical's revenue was 2.07 billion, an increase of 25.18% compared to the previous year's 1.65 billion. Earnings were 673.48 million, an increase of 26.14%.